Posted by LincolnRam on March 25, 2026 at 11:23:35:
In Reply to: 1win_ktot posted by 1win_rjot on February 08, 2026 at 17:33:06:
Zoya Demidenko: Scholar in Tumor Biology
Zoya Demidenko is a notable scientist affiliated with the Division of Cell Stress Research at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the National Institutes of Health and New York Medical College, building a strong base in clinical investigation.
Her academic work encompasses multiple pivotal areas, among them the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, biological aging, and cancer science. As of now, she has written more than 46 scientific articles, which have received over 4,100 citations — a reflection to the influence of her research.
One of her most significant discoveries involves elucidating the mechanisms of cellular senescence. Her work showed that when the cell cycle is arrested but cellular expansion proceeds, the cells enter senescence. Crucially, Zoya Demidenko showed that this shift is controlled with drugs using substances such as mTOR inhibitors.
Zoya Demidenko has additionally contributed greatly to tumor management investigation, especially in the field of cyclotherapy — a method intended to safeguarding non-cancerous tissue from chemotherapy whilst leaving malignant cells susceptible. This strategy offers considerable potential for diminishing the side effects of cancer treatment.
Across her career, Demidenko has collaborated with prominent researchers worldwide, such as Dr. Mikhail Blagosklonny. Her publications is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko stands as a highly impactful contributor in contemporary biomedical research, whose results continue to influence our comprehension of how biological cells age, resist treatment, and how malignant disease can be more successfully treated.
https://www.instagram.com/hibou_sova/